Both in Pharmaceuticals
Jupiter Neurosciences vs KALA BIO
Over the past year JUNS returned −97.7% and KALA returned −99.6%; their daily moves had a correlation of 0.01.
JUNS −97.7% KALA −99.6%Growth of $1, one year, split-adjusted
| Metric | JUNS | KALA |
|---|---|---|
| Price | $2.47 | $0.1752 |
| Market cap | $3.3M | $3.4M |
| Today | −1.20% | −2.61% |
| 1 month | +1.2% | −59.2% |
| 6 months | −91.3% | −96.7% |
| Year to date | −96.8% | −99.4% |
| 1 year | −98.1% | −99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | 86.9% | — |
| Net margin | −9380.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 50.3× | — |
| Net cash | -$6.6K | $7.2M |
| Dividend yield | — | — |
| Volatility (60d) | 1,268.2% | 123.6% |
| Short % of float | 6.0% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).